Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Orca-T | Read more
Bringing precision to life
Orca Bio is on a mission to deliver the promise of cell therapy to patients without compromise
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. Our investigational allogeneic T-cell immunotherapies harness the power of regulatory T cells with the hope of providing better outcomes with fewer risks for patients.
At Orca Bio, we believe all patients deserve a chance at a cure
We don’t settle, and we believe patients shouldn’t have to
If you are interested in joining our team, learn about our collaborative culture and patient-driven mission.
Stay up to date with our developments—review our press releases in the newsroom.